Sticky post

Breathing easier. Scientists from 1973 already knew that inhaling cannabis could open up airways in the lungs.

Inhaling cannabis makes for easier breathing, because it dilates – or opens up – the airways in the lungs, according to a 1973 study published in New England Journal of Medicine. 
Continue reading Breathing easier. Scientists from 1973 already knew that inhaling cannabis could open up airways in the lungs.

Sticky post

Tetra Bio-Pharma first-past-the-post on clinical trial for chronic pain

Tetra Bio-Pharma and clinical research partner Santé Cannabis conduct first-ever and most exhaustive clinical trial to evaluate safety and efficacy of different doses and ratios of cannabis oils versus placebo for (non-cancer) chronic pain. On track for completion later this fall.
Continue reading Tetra Bio-Pharma first-past-the-post on clinical trial for chronic pain

Health Canada makes Tetra Bio-Pharma cannabis-delivery product a Class Two medical device.

Heath Canada decision to reclassify, to a Phase Two medical device, the @TetraBioPharma inhalation pipe for cannabis medication means that patients suffering cancer pain may soon be able to claim the cost through their private and public insurance plans. Continue reading Health Canada makes Tetra Bio-Pharma cannabis-delivery product a Class Two medical device.

Sticky post

Aphria signs deal; exclusive global partner for QuickStrip

Aphria and Canadian bio-technology company Rapid Dose Therapeutics have signed an MOU that Aphria will have exclusive global preferred rights to produce, distribute and sell QuickStrip(TM) products for cannabis markets around the world, once a definitive agreement is signed between the two companies in the near future. Continue reading Aphria signs deal; exclusive global partner for QuickStrip

Sticky post

“Old” cannabis-plant research finally sees the light of day, as the stigma of cannabis slowly melts away

The potential healing properties of cannabis are becoming increasingly evident. Hundreds of thousands of studies have been done in search of better treatment for diseases involving just about every system and organ in the body.
Continue reading “Old” cannabis-plant research finally sees the light of day, as the stigma of cannabis slowly melts away

Escrow-release deadline extended for Canaccord deal with Columbia Care

Canaccord Genuity Growth Corp. (CGG) yesterday provided an update on its agreement with Columbia Care, a leading medical cannabis company in the United States.

CGG has obtained approval to extend the Escrow Release Deadline, as per an amendment of the subscription receipt agreement terms. Continue reading Escrow-release deadline extended for Canaccord deal with Columbia Care

Multiple clinical-trial records on negative aspects of cannabis were updated this week.

Several studies on cannabis dependance & withdrawal, registered and completed as far back as 2013, were updated yesterday and today.  Updated records show Jan 14 or 15 as last date the clinical trial met “Quality Control” criteria.  Continue reading Multiple clinical-trial records on negative aspects of cannabis were updated this week.